Concise Prescribing Info
Loratadine 5 mg, pseudoephedrine sulphate 120 mg
Symptomatic relief of allergic rhinitis & common cold including nasal congestion, sneezing, rhinorrhea, pruritus & lacrimation.
Dosage/Direction for Use
Adult & childn ≥12 yr 1 cap bd.
May be taken with or without food.
Hypersensitivity or idiosyncrasy to loratadine, pseudoephedrine sulphate, adrenergic agents or drugs of similar chemical structure. Narrow angle glaucoma, urinary retention, severe HTN & CAD, hyperthyroidism. Patients receiving MAOI therapy or w/in 14 days of discontinuation.
Special Precautions
Discontinue use approx 48 hr prior to skin testing. Glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, prostatic hypertrophy or bladder neck obstruction, CV disease, increased IOP or DM. Concomitant use w/ digitalis. Prolonged use, high doses. Avoid abrupt w/drawal. Severe hepatic impairment. Pregnancy & lactation. Childn <12 yr. Elderly ≥60 yr.
Adverse Reactions
Insomnia, dry mouth, headache, somnolence.
Drug Interactions
Increased plasma conc w/ ketoconazole, erythromycin, cimetidine. Hypertensive reactions including hypertensive crises w/ MAOIs. Reduced antihypertensive effects of methyldopa, mecamylamine, reserpine, veratum alkaloids. Increased ectopic pacemaker activity w/ digitalis. Increased absorption rate w/ antacids. Decreased absorption rate w/ kaolin. Concomitant use w/ β-blockers.
ATC Classification
R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.
Carinox cap
50 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in